6-year-old in China dies after experimental treatment, investigation finds, raising questions about the country's gene therapy regulations

livescience - A young girl in China died after being given an experimental gene therapy intended to treat a neurodevelopmental syndrome, an investigation by Science and Retraction Watch revealed.

AI Summary: An investigation found a six‑year‑old patient died following an experimental gene‑editing treatment in China, and that the fatality was not promptly disclosed. The case has reignited scrutiny of the country’s gene therapy oversight and raised urgent questions about trial transparency, consent and regulatory enforcement.

#healthcare #publichealth #governmentpolicy #biotech #clinicaltrials #genetherapy #genetics

14 hrs / livescience

15 hrs / medicalxpress


Back to Top / Sat, July 25, 2026, 12:23 am / permalink 27637 / 2 stories in 3 hrs /




Related Stories


Single‑infusion gene editing dramatically lowers LDL cholesterol in early trial / 7 wks

AI model identifies improved cancer outcomes globally / 6 months

Scientists precisely edit human embryo genes, reigniting safety debate / 7 wks

Gene therapy restores hearing in about 90% of trial participants / 3 months

FDA scrutinizes peptide injections popularized by RFK Jr. and influencers / 46 hrs

Personalized genetic therapy yields improvements in children with rare epilepsy / 2 days

White House proposes double-digit HHS cuts and reorganization plan / 3 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Diagnostics, Cancer Screening, Medicare Advantage (not listed), Adolescent Health and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.